THIS NOTICE IS BEING POSTED TO THE BIOSCI, BIONEWS, GNOME-PR
AND EMPLOYMENT BB'S. PLEASE EXCUSE ANY DUPLICATIONS YOU RECEIVE.
Dear Colleagues,
The Applied Molecular Biology Group of Du Pont, within
Pharmaceutical Research and Development of Medical Products has
immediate openings for two Principal Investigators. Our focus
is to provide new approaches, tools and targets through
molecular biology that, when combined with our strong
conventional drug discovery programs, will lead to new
therapeutics. The new positions offer exciting opportunities
for Ph.D. scientists with strong molecular biology backgrounds
to work as part of interdisciplinary research groups with
pharmacologists and medicinal chemists in a highly team-oriented
environment with an equal-opportunity employer. Successful
candidates should have at least 2 years of post-doctoral
experience and expertise in one of the following areas:
MAMMALIAN EXPRESSION SYSTEMS: Demonstrated experience in the
expression of recombinant genes in mammalian tissue culture
systems is essential. Design and utilization of a variety of
vector systems and host cells is preferred. A background in the
development of engineered mammalian cell lines for
pharmaceutical screening is desirable.
RECEPTOR CLONING: Experience in cDNA cloning and a strong
background in recombinant DNA technology is required.
Preference will be given to candidates with experience in the
molecular biollogy of receptors or membrane proteins. A
background in expression cloning, subtractive hybridization,
cell sorting or neuroscience would be advantageous.
Interested molecular biologists may reply to this message or
may respond to: AMB Search Committee, c/o Barbara Sahagan,
DuPont Experimental Station E400/5219, P.O. Box 80400,
Wilmington, DE. 19880.
